Cancer Health Treatment Update
FDA Approves Keytruda Immunotherapy for Operable Lung Cancer

The checkpoint inhibitor is now indicated for pre- and post-surgery treatment of Stage II or III non-small-cell lung cancer.

More Aggressive Treatment for Metastatic Colorectal Cancer Doesn’t Impact Quality of Life
Removing as much tumor as possible did not decrease quality of life despite an increase in adverse events.
When Your Cancer’s Incurable and Folks Constantly Ask, “How Are You?”

To that awkward greeting, Richard Wassersug, PhD, who has lived with prostate cancer over 25 years, crafted an apt answer—and a call to action.

Liver Cancer Declined After Advent of Hepatitis C Treatment

Hepatocellular carcinoma among people with HCV fell after the debut of direct-acting antivirals, but cases are rising for those without viral hepatitis.

Cancer Health Fall 2023
Check out our new print edition!
Medicare Enrollees Can Switch Coverage Now. Here’s What’s New and What to Consider.

New limit on out-of-pocket drug costs will help people who take expensive medications for conditions like cancer or hepatitis.

Advertisement
COVID-19 Intranasal Vaccine Candidate Produces Robust Immune Response

The live-attenuated vaccine aims to produce an immune response to the entire virus rather than the frequently mutating spike protein.

More News About COVID-19
See all Cancer Health's coverage of COVID-19, including how it affects people living with cancer. For more news about the SARS-CoV-2 coronavirus, visit our sister site, COVID Health.com.

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to [email protected] by [email protected]. Please remember to add [email protected] to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2023 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.